Edited by: Paul Smaglik
 DEATH DUEL: One TNF receptor 1 pathway activates apoptosis, another triggers gene expression-roles in seeming opposition, says David Goeddel. |
Comments by David V. Goeddel, Tularik Inc., San Francisco
Two of the most important activities of the common cytokine tumor necrosis factor (TNF) are to signal apoptosis and to initiate NF-kappa B activation. The signaling starts at the TNF receptor 1 (TNFR1) and moves downstream in a series of biochemical reactions, which until recently were mostly unknown.
"This paper really starts to show how complex the TNF receptor 1 signaling pathway is," says David V. Goeddel, CEO of Tularik Inc., a San Francisco-based biotech company engaged in developing new pharmaceutical products....
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
